載入...
CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice
Bone marrow failure and hematopoietic damage is one of the major consequences of irradiation-induced lethality. There is an immediate need to develop medical countermeasures (MCMs) to combat irradiation-induced lethality. We tested the efficacy of CDX-301, developed by Celldex Therapeutics Inc., in...
Na minha lista:
| 發表在: | Sci Rep |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7000413/ https://ncbi.nlm.nih.gov/pubmed/32019942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-58186-1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|